Occudo Quantitative Strategies’s Boston Scientific BSX Stock Holding History

Occudo Quantitative Strategies’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.9M	Buy	397,122 +244,084	+159%	+$13.3M	0.9%	14
2026 Q1	$8.82M	Sell	153,038 -24,028	-14%	-$1.92M	0.48%	48
2025 Q4	$16.9M	Buy	177,066 +81,744	+86%	+$8.01M	1.13%	2
2025 Q3	$9.31M	Buy	95,322 +10,838	+13%	+$1.12M	1.13%	4
2025 Q2	$9.07M	Buy	84,484 +12,425	+17%	+$1.26M	1.02%	5
2025 Q1	$7.16M	Buy	72,059 +45,568	+172%	+$4.59M	0.95%	10
2024 Q4	$2.37M	Sell	26,491 -4,797	-15%	-$422K	0.43%	53
2024 Q3	$2.62M	Sell	31,288 -39,535	-56%	-$3.12M	0.48%	42
2024 Q2	$5.45M	Buy	70,823 +66,160	+1,419%	+$4.84M	0.97%	7
2024 Q1	$319K	Buy	+4,663	New	+$300K	0.06%	449
2021 Q3	–	Sell	-25,477	Closed	-$1.09M	–	1019
2021 Q2	$1.09M	Buy	+25,477	New	+$1.07M	0.17%	191
2021 Q1	–	Sell	-6,866	Closed	-$247K	–	763
2020 Q4	$247K	Buy	+6,866	New	+$247K	0.08%	477

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Occudo Quantitative Strategies's BSX Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its Boston Scientific (BSX) stake by 159% in Q2 2026, buying an estimated $13.3M and bringing the position to 397,122 shares worth $16.9M. The position accounts for 0.9% of the portfolio, ranked #14.

Occudo Quantitative Strategies first reported a position in BSX in Q4 2020 and has held it in 12 quarters since. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Occudo Quantitative Strategies held 397,122 shares of Boston Scientific worth $16.9M as of Q2 2026.
Occudo Quantitative Strategies bought 244,084 Boston Scientific shares in Q2 2026, an estimated $13.3M.
Boston Scientific made up 0.9% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #14 holding.
Occudo Quantitative Strategies first reported a position in Boston Scientific in Q4 2020 and has held it in 12 quarters since.
1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.